Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Luceco (LUCE) by Berenberg
- Overweight Oxford Nanopore Technologies (ONT) by Barclays
- Overweight Fevertree Drinks (FEVR) by Barclays
- Buy YouGov (YOU) by Deutsche Bank
- Hold Fevertree Drinks (FEVR) by Deutsche Bank
- Buy Bellway (BWY) by Citi
- Neutral Kingfisher (KGF) by Goldman Sachs
- Buy Rolls-Royce Holdings (RR.) by Goldman Sachs
- Outperform National Grid (NG.) by Bernstein
- Outperform SSE (SSE) by Bernstein
- Overweight Croda International (CRDA) by Morgan Stanley
- Hold Kingfisher (KGF) by Berenberg
- Sector Perform Mobico Group (MCG) by RBC Capital
- Overweight BP (BP.) by Morgan Stanley
- Equal Weight Shell (SHEL) by Morgan Stanley
- Overweight Bellway (BWY) by JP Morgan
- Avoid RTC Group (RTC) by Steve Moore in ShareProphets
- Watch Tandem Group (TND) by Steve Moore in ShareProphets
- Buy M. P. Evans Group (MPE) by Canaccord Genuity
- Buy Michelmersh Brick Holdings (MBH) by Canaccord Genuity
Physiomics (PYC) Share Price
Health Care Sector
NOTE: This is based on 19 open tips for Physiomics (PYC)
| Latest Bid : 0.43p | Latest Ask : 0.48p |
| High Today : 0.47p | Low Today : 0.42p |
| This Years High : 0.62p | This Years Low : 0.26p |
| Volume : 9,899,921 | MKT Cap : £0.93M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Stock Splits and Consolidations
19/12/2016 – Stock Consolidation 100.000:1.000
Physiomics (PYC) Overview
Physiomics' vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.Physiomics (PYC) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2026-02-16 16:20:00 16/02/2026 | 9.00% |
| Avoid | Steve Moore | Premium Only | 2025-02-13 13:45:00 13/02/2025 | 9.00% |
| Avoid | Steve Moore | Premium Only | 2024-09-27 09:25:00 27/09/2024 | 24.17% |
| Avoid | Steve Moore | Premium Only | 2024-07-03 12:05:00 03/07/2024 | 24.17% |
| Avoid | Steve Moore | Premium Only | 2024-05-03 14:25:00 03/05/2024 | 62.08% |
Physiomics (PYC) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 0.43p | Latest Ask : 0.48p |
| High Today : 0.47p | Low Today : 0.42p |
| This Years High : 0.62p | This Years Low : 0.26p |
| Volume : 9,899,921 | MKT Cap : £0.93M |
Physiomics Overview
Physiomics' vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Physiomics Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2026-02-16 16:20:00 16/02/2026 | 9.00% |
| Avoid | Steve Moore | Premium Only | 2025-02-13 13:45:00 13/02/2025 | 9.00% |
| Avoid | Steve Moore | Premium Only | 2024-09-27 09:25:00 27/09/2024 | 24.17% |
| Avoid | Steve Moore | Premium Only | 2024-07-03 12:05:00 03/07/2024 | 24.17% |
| Avoid | Steve Moore | Premium Only | 2024-05-03 14:25:00 03/05/2024 | 62.08% |
Stock Splits and Consolidations
19/12/2016 – Stock Consolidation 100.000:1.000